Publications by authors named "N Girard"

Claim this Profile
R
Real-World Characteristics, Treatment Patterns, and Outcomes in Advanced HER2 (ERBB2)-Mutant Non-Small Cell Lung Cancer: A Retrospective Study of Single Centers in France and Germany.
Petros Christopoulos, Christin Assmann, Lirong Zhang, Kyle Dunton, Ahmed Ali, Nicolas Girard

Clin Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of patients with curative-intent treatment for primary pulmonary sarcoma: Results from an international multicenter retrospective study.
Stephane Collaud, Theresa Stork, Dagmar Adamkova, Clemens Aigner, Ivan Bravio, Nicolas Girard

JTCVS Open· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world management of unresectable stage III non-small-cell lung cancer: Impact of durvalumab consolidation therapy in French clinical practice.
Christos Chouaid, Philippe Giraud, Marie Wislez, Eric Pichon, Alma Stancu, Nicolas Girard

Respir Med Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amivantamab-Chemotherapy in Non-Small Cell Lung Cancer with EGFR Exon 20 Insertions: Impact of Treatment Crossover and Other Endpoints from the Phase III PAPILLON Study.
Rachel E Sanborn, Caicun Zhou, Ke-Jing Tang, Byoung Chul Cho, Susanna Cheng, Nicolas Girard

Target Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer. Reply.
Patrick M Forde, Mariano Provencio, Nicolas Girard

N Engl J Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis